Encrypgen has come up with a ‘gene-chain’ that seeks to redefine the way gene-related information is shared and they are holding an Initial Coin Offering (ICO) or a crowd sale to raise funds. (Photo: EncrypGen).

EncrypGen, the blockchain solution company for the genetic market, announced earlier this month that it has entered into strategic partnership with Health Wizz, a free mobile platform to allow consumers to efficiently and securely manage their various health records. In addition, EncrypGen also announced that it now sells Codigo46 DNA tests.

“Both developments are in anticipation of our imminent ‘MyGene-ChainTM’ service, which enables people to take control of their genomic data from testing to storage and to share it with their physicians. These developments have important, industry-wide implications. Consumers will finally have the ability to control their data and monetize it with EncrypGen’s proprietary $DNA token. Thanks to this vertical solution, no one will need to guess who owns and has access to their genetic data because the answer is simple: You Own You! These are the first of many anticipated strategic alliances to be announced by EncrypGen,” commented Dr. David Koepsell, CEO, EncrypGen, LLC.

EncrypGen and Codigo46 have stated that their partnership will include the sales of Codigo46’s genetic testing kits through EncrypGen’s website at their new Preferred Vendor Storefront. EncrypGen’s blockchain genomics platform is built to ensure the security and privacy of genomic data, both for commercial entities and for individuals. The company’s flagship product – Gene-ChainTM – is a private, permissioned blockchain for the secure transmission of de-identified genetic data. The Gene-ChainTM allows individuals and companies, to safely store genetic test results while enabling scientists to search and purchase patients’ data and to pay individuals for the right to use it. Codigo46 bought EncrypGen’s first beta-license and offers genetic testing for ancestry, health, and pharmacogenomics.

EncrypGen is also announcing important strategic alliance with Health Wizz. The Health Wizz mobile platform leverages mobile, data management and blockchain technology to provide consumers with the tools they need to aggregate, manage and share their medical data with various stakeholders, including research organizations and pharmaceutical companies, all while ensuring data integrity and protecting patient’s privacy. The two companies will be working together to integrate EncrypGen’s Gene-ChainTM into the Health Wizz ecosystem over the coming months.